← back to search

Henrik J. Johansson

Science for Life Laboratory · SE
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, and Advanced Proteomics Techniques and Applications.
h-index
40
citations
8,573
works
156
NIH funding
primary concept
email

Recent publications

The DNA methylation landscape of primary triple-negative breast cancer
Nature Communications 2025cited by 19position: middledoi
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
Nature Communications 2024cited by 23position: middledoi
Molecular Profiling Defines Three Subtypes of Synovial Sarcoma
Advanced Science 2024cited by 8position: middledoi
FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress
Molecular Cell 2023cited by 15position: middledoi
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
Nature Cancer 2021cited by 113position: middledoi
Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation
Proceedings of the National Academy of Sciences 2021cited by 80position: middledoi
DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis
Molecular & Cellular Proteomics 2020cited by 290position: middledoi
Breast cancer quantitative proteome and proteogenomic landscape
Nature Communications 2019cited by 235position: firstdoi
MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
iScience 2019cited by 93position: middledoi
Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow
Nature Communications 2018cited by 153position: middledoi
Heterogeneity and interplay of the extracellular vesicle small RNA transcriptome and proteome
Scientific Reports 2018cited by 140position: middledoi
Extracellular nanovesicles released from the commensal yeast Malassezia sympodialis are enriched in allergens and interact with cells in human skin
Scientific Reports 2018cited by 86position: firstdoi
<i>MYCN</i> -amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling
Proceedings of the National Academy of Sciences 2018cited by 70position: middledoi
Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3
BMC Biology 2018cited by 65position: middledoi
Cells release subpopulations of exosomes with distinct molecular and biological properties
Scientific Reports 2016cited by 946position: middledoi
Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling
Stem Cells 2016cited by 536position: middledoi
Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties
Nanomedicine Nanotechnology Biology and Medicine 2015cited by 662position: middledoi
Serum‐free culture alters the quantity and protein composition of neuroblastoma‐derived extracellular vesicles
Journal of Extracellular Vesicles 2015cited by 185position: middledoi
In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
Stem Cells Translational Medicine 2015cited by 162position: middledoi
HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics
Nature Methods 2013cited by 285position: middledoi
Genomic Insights into the Atopic Eczema-Associated Skin Commensal Yeast <i>Malassezia sympodialis</i>
mBio 2013cited by 127position: middledoi
Defining, Comparing, and Improving iTRAQ Quantification in Mass Spectrometry Proteomics Data
Molecular & Cellular Proteomics 2013cited by 65position: lastdoi
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
Nature Communications 2013cited by 63position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Janne Lehtiö · Karolinska University Hospital18 papers (2013–2024)Samir EL Andaloussi · Karolinska University Hospital5 papers (2015–2018)Lukas M. Orre · Science for Life Laboratory4 papers (2013–2023)Matthew J. A. Wood · University of Oxford4 papers (2015–2018)Imre Mäger · Zogenix (United States)4 papers (2015–2018)Yi Lee · Karolinska Institutet4 papers (2015–2018)Oscar P. B. Wiklander · Karolinska University Hospital3 papers (2015–2018)Joel Z. Nordin · Karolinska University Hospital3 papers (2015–2018)Jenny Forshed · Science for Life Laboratory3 papers (2013–2013)Rui M. Branca · Science for Life Laboratory3 papers (2013–2018)Pieter Vader · Utrecht University3 papers (2015–2016)Yafeng Zhu · Sun Yat-sen University2 papers (2018–2020)Mattias Vesterlund · Science for Life Laboratory2 papers (2016–2018)Johanna Dzieran · Pfizer (Germany)2 papers (2018–2019)Mikael Huss · Stockholm University2 papers (2013–2018)Lina Hultin Rosenberg · Science for Life Laboratory2 papers (2013–2013)Marie Arsenian‐Henriksson · Karolinska Institutet2 papers (2018–2019)Angelika Schmidt · Merck KGaA, Darmstadt (Germany)1 papers (2018–2018)Adarsh K. Mayank · University of California, Los Angeles1 papers (2023–2023)Åsa Pérez-Bercoff · UNSW Sydney1 papers (2013–2013)